Showing results (251-260 of 521) with videos related to

Sort By:
Pageof 53
Vaccine|April 3, 2010
A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccinationThierry Van Effelterre, Matthew R Moore, Frederik Fierens, et al.
Current Research in Microbial Sciences|December 15, 2022
Distinct epidemiological profiles of porcine circovirus 3 and fox circovirus in Canadian foxes (Vulpes spp.)Marta Canuti, Bruce Rodrigues, Émilie Bouchard, et al.
Vaccine|June 23, 2007
Herd immunity and pneumococcal conjugate vaccine: a quantitative modelMichael Haber, Albert Barskey, Wendy Baughman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
IL-18, but not IL-12, regulates NK cell activity following intranasal herpes simplex virus type 1 infectionPatrick C Reading, Paul G Whitney, Daniel P Barr, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccineMathias W R Pletz, Lesley McGee, James Jorgensen, et al.
Physical Review Letters|February 28, 2002
Optimal wire-number range for high x-ray power in long-implosion-time aluminum Z pinchesC A Coverdale, C Deeney, M R Douglas, et al.
Vaccine|July 30, 2008
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adultsJennifer C Nelson, Michael Jackson, Onchee Yu, et al.
Neurology. Clinical Practice|July 10, 2020
Clinical factors associated with mood affective disorders among adults with cerebral palsyDaniel G Whitney, Seth A Warschausky, Daniel Whibley, et al.
Bone|November 7, 2016
Cortical bone deficit and fat infiltration of bone marrow and skeletal muscle in ambulatory children with mild spastic cerebral palsyDaniel G Whitney, Harshvardhan Singh, Freeman Miller, et al.
MMWR. Morbidity and Mortality Weekly Report|September 19, 2014
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)Sara Tomczyk, Nancy M Bennett, Charles Stoecker, et al.
Pageof 53